Your browser doesn't support javascript.
loading
Advances in molecular markers of germ cell cancer in patients with disorders of sex development.
van der Zwan, Yvonne G; Cools, Martine; Looijenga, Leendert H J.
Afiliação
  • van der Zwan YG; Department of Pathology, Erasmus MC - University Medical Center Rotterdam, Josephine Nefkens Institute, Rotterdam, The Netherlands.
Endocr Dev ; 27: 172-84, 2014.
Article em En | MEDLINE | ID: mdl-25247654
ABSTRACT
The risk of malignant transformation of germ cells, leading to germ cell cancer (GCC) in patients with disorders of sex development, is highly heterogeneous and dependent on a number of parameters, of which the presence of Y-chromosomal material is essential. This chapter describes the networks, both protein-coding and regulatory processes, related to normal gonadal development and GCC, with focus on recent advances of molecular markers for early diagnosis.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos do Desenvolvimento Sexual / Biomarcadores Tumorais / Neoplasias Embrionárias de Células Germinativas Tipo de estudo: Screening_studies Limite: Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos do Desenvolvimento Sexual / Biomarcadores Tumorais / Neoplasias Embrionárias de Células Germinativas Tipo de estudo: Screening_studies Limite: Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article